History of TMS Therapy

Noninvasive brain stimulation as we currently know it was introduced in 1985 as a diagnostic tool for studying brain function. Early researchers discovered that magnetic pulses could stimulate neural activity in targeted regions of the brain, which provided new possibilities for understanding and treating neurological and psychiatric conditions. Researchers initially focused on exploring the potential of TMS for mapping brain activity, but in the 1990s, they began investigating its therapeutic applications, particularly for depression. Clinical trials demonstrated that targeted stimulation of the prefrontal cortex could improve mood and alleviate symptoms in patients with major depressive disorder (MDD).

By 2008, the U.S. Food and Drug Administration cleared TMS therapy for treating MDD in patients who had not responded to antidepressants. This milestone marked the beginning of widespread acceptance of TMS as a viable mental health treatment. Over the next decade, advancements in technology and technique improved the precision and effectiveness of the procedure. Today, NeuroStar TMS therapy is recognized as an evidence-based treatment for various mental health conditions, including depression, anxious depression, and obsessive-compulsive disorder.